Blood · 1999 · 114 citations · 110 references
MedicineHematologyInfectious DiseasesHepatologyStem Cell TransplantationVirologyAntiviral TherapyLiver TransplantationTransplant ComplicationsTransplant Infectious ComplicationsTransplant RejectionViral HepatitisDonor Fatigue ManagementDonor Lifecycle ManagementDonor Temperature ManagementHepatitis Antiviral StewardshipPost-transplant Cytomegalovirus InfectionViral Hepatitis PreventionViral Hepatitis Transmission
H EMATOPOIETIC CELL transplantation (HCT) is performed annually in over 30,000 patients worldwide for a range of underlying disorders including hematologic malignancy, severe aplastic anemia, solid tumors, and genetic diseases.[1][1] While the risk of acquiring hepatitis virus infection from
110
Chronic graft-versus-host syndrome in man
Howard M. Shulman, Keith M. Sullivan, Paul L. Weiden et al. · The American Journal of Medicine · 1980 · 2.4K citations
Life Sciences, Immunology, Surgery +10
Molecular Cloning and Disease Association of Hepatitis G Virus: A Transfusion-Transmissible Agent
Jeff Linnen, J. Wages, Z Y Zhang-Keck et al. · Science · 1996 · 1.4K citations
Clinical Outcomes after Transfusion-Associated Hepatitis C
Myron J. Tong, Neveen S. El-Farra, Andrew R. Reikes et al. · New England Journal of Medicine · 1995 · 1.2K citations · Full text